Stock market
Biotech stocks are surging. How investors can play the new drug innovation boom
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
Related discussion groups
No group discusses this yet. Start a discussion group and attach this story.
More on Stock market
- 『エルメスまでも』高級品「最後の砦」揺らぐ…株価40％超急落
- Wall Street Journal: Trump razmatra nove udare na IranAMERIČKI predsjednik Trump razmatra nove vojne udare na Iran zbog navodnih prijetnji. SAD jača vojnu prisutnost na Bliskom istoku slanjem dodatnih brodova i marinaca uoči izbora za Kongres.
- Defer Nov 1 rally, will hit festive business, traders urge Rahul; BJP raps CongressCTI chairman Brijesh Goyal said Delhi records Rs 25,000 crore in business on Dhanteras across major sectors. CTI claimed that traders suffered losses of Rs 3,000 crore in Oct due to rallies and roa...
- Wall Street Journal u posjedu vojnih dokumenata: Trump razmatra pokretanje novog velikog rataAmerički predsjednik Donald Trump razmatra pokretanje nove velike vojne operacije protiv Irana, a Pentagon mu je predstavio nekoliko mogućnosti napada
- AI funding fears rattle Wall Street. Here's how we're adjusting our portfolioThe rotation out of AI stocks benefited several defensive Club stocks.
- New Middle East Threats, Russian Diesel Coming to USThe news doesn’t stop when markets close. Hosts David Gura, Christina Ruffini and Lisa Mateo bring clarity, context and a bit of humor to the weekend’s biggest headlines, LIVE from New York. Joined...